Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
Clinical trial NCT05246280 · TERMINATED
Trial details
- NCT number
- NCT05246280
- Sponsor
- Navidea Biopharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2024-07-09
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.